Key Personnel Changes Omeros Corporation has recently appointed key executives like the chief accounting officer and chief medical officer. Engaging with these new decision-makers could present sales opportunities to showcase products or services.
Product Development Omeros Corp. has launched innovative treatments such as narsoplimab for specific medical conditions. Understanding these products and their market potential could lead to collaborations or sales partnerships.
Funding Achievements With recent financing of $6.7M and grants worth millions, Omeros has the resources for growth and product expansions. Positioning relevant solutions aligned with their focus areas can be a strategic sales approach.
Asset Sales Omeros Corporation recently completed significant asset sales transactions totaling $1B. Exploring opportunities related to these divestitures or offering complementary services can be a way to engage with the company.
Market Differentiation In a competitive landscape with similar biotech companies, Omeros stands out with its unique focus on inflammation, coagulopathies, and central nervous system disorders. Tailoring sales pitches to address specific unmet needs in these areas could resonate with the company.
296
$50M$100M
51$10M
166$10M$50M
268$10M$50M
51$10M$50M
177$10M$50M
134$10M$50M
201$50M$100M
187$10M$50MOmeros Corporation uses 8 technology products and services including Oracle Taleo, SAS, Shopify, and more. Explore Omeros Corporation's tech stack below.
| Omeros Corporation Email Formats | Percentage |
| FLast@omeros.com | 65% |
| Last@omeros.com | 23% |
| LFirst@omeros.com | 7% |
| First.Last@omeros.com | 5% |
Biotechnology ResearchWashington, United States201-500 Employees
Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Company Overview
Media & News
Funding & FinancialsOmeros Corporation has raised a total of $6.7M of funding over 23 rounds. Their latest funding round was raised on Apr 10, 2023 in the amount of $6.7M.
Omeros Corporation's revenue is in the range of $10M$50M
Funding & FinancialsOmeros Corporation has raised a total of $6.7M of funding over 23 rounds. Their latest funding round was raised on Apr 10, 2023 in the amount of $6.7M.
Omeros Corporation's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com